As the use of molecular diagnostics increases -- amid the race to $1,000-or-less genomic sequencing -- McKesson and the American Medical Association (AMA) have entered into a licensing partnership to ...
Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.
Abstract This paper discusses the administrative aspects of molecular diagnostics in oncology, including US Food and Drug Administration (FDA) oversight, the regulatory approval process, clinical, and ...
Molecular diagnostic (MDx) tests should provide results quickly and reliably. By choosing instruments, reagents, software, services, and support offerings that exist in a single MDx ecosystem, ...
CRISPR gene editing and next-generation sequencing (NGS) have transformed clinical and life sciences research. CRISPR permits the selective targeting and editing of specific nucleotide sequences, with ...
The University of Alabama at Birmingham Departments of Pathology and Genetics jointly offer a one-year ACGME accredited fellowship in molecular genetic pathology. The fellowship is designed to train ...
Franklin Lakes-based BD (Becton, Dickinson and Co.) on Aug. 25 announced the launch of a new, fully automated high-throughput diagnostic system for U.S. labs Using robotics and sample management ...
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback